Dear MPIP Community Members,
Last week, Dr. Keith Flaherty recorded a webinar with us to provide an update on the research and key findings presented at the November 2014 SMR (Society for Melanoma Research) meeting held in Zurich, Switzerland. To access the webinar, please click here. Your name and email address are requested to track the number of visits only.
If you have any questions, comments or topics for future webinars, please contact me directly at education@melanoma.org. Have a great evening!
Sincerely,
Shelby – MRF
About Dr. Keith Flaherty
Dr. Flaherty is director of the Henri and Belinda Termeer Center for Targeted Therapies at the Massachusetts General Cancer Center and Associate Professor of Medicine at Harvard Medical School. Dr. Flaherty’s research and clinical focus is therapies for melanoma, with a particular expertise in targeted therapies.
About the Society for Melanoma Research
- The SMR is an organization of scientific and medical investigators devoted to alleviating the suffering of people with melanoma
- It was founded to unify the field by increasing communication among researchers and building bridges of collaboration between basic, translational and clinical investigators
- The SMR holds annual meetings to provide researchers an opportunity to collaborate, meet and share ideas about all forms of melanoma research
.
.
